A61P 1/16

Technology



back to "A61P 1/16" profile

More Results

Showing 1 to 20 of 99 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
9993524 Prophylactic or therapeutic agent for hepatic diseasesApr 26, 13Jun 12, 18Not available
9925228 Medicinal orobancheace extractsFeb 18, 15Mar 27, 18Not available
9868743 Macrocyclic molecules as HCV entry inhibitorsFeb 04, 14Jan 16, 18BRISTOL-MYERS SQUIBB COMPANY
9815876 Chimeric inhibitor molecules of complement activationMar 04, 11Nov 14, 17OMEROS CORPORATION, KOBENHAVNS UNIVERSITET,
9663573 Methods of treating liver conditions using Notch2 antagonistsApr 06, 12May 30, 17Genentech, Inc.
9623071 Modulation of hepatitis B virus CCCDNA transcriptionMay 31, 13Apr 18, 17BARUCH S. BLUMBERG INSTITUTE
9572776 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acidsJan 20, 10Feb 21, 17CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS DESCARTES,
9556129 Phosphatidylcholine transfer protein inhibitorsJul 29, 15Jan 31, 17THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
9549961 Composition for preventing or treating liver toxicity comprising Galgeuntang or lactic acid bacteria fermented GalgeuntangJun 25, 13Jan 24, 17KOREA INSTITUTE OF ORIENTAL MEDICINE
9540648 Therapeutic use of activators of zinc finger protein GL13Jan 25, 13Jan 10, 17UNIVERSITAET LEIPZIG
9522163 Methods of treating hepatitisDec 02, 13Dec 20, 16UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, YALE UNIVERSITY,
9512156 Carbon monoxide releasing rhenium compounds for medical useMar 04, 11Dec 06, 16UNIVERSITAT ZURICH
9480692 Sulfated-oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferationApr 17, 15Nov 01, 16VIRGINIA COMMONWEALTH UNIVERSITY
9433621 Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsFeb 18, 11Sep 06, 16MERCK SHARP & DOHME CORP., SOUTHERN RESEARCH INSTITUTE,
9428469 Antiviral compoundsFeb 27, 14Aug 30, 16F. HOFFMANN-LA ROCHE AG
9393303 Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitisFeb 21, 12Jul 19, 16ACADEMISCH ZIEKENHUIS MAASTRICHT, UNIVERSITEIT MAASTRICHT,
9393315 Compounds for targeting drug delivery and enhancing siRNA activityJun 08, 12Jul 19, 16NITTO DENKO CORPORATION
9387222 Alginate biomaterials for the treatment of hepatic disordersNov 27, 08Jul 12, 16BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY, HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.,
9365574 Soluble guanylate cyclase activatorsMay 24, 11Jun 14, 16MERCK SHARP & DOHME CORP.
9351973 Pyrazolopyridyl compounds as aldosterone synthase inhibitorsSep 17, 12May 31, 16MERCK SHARP & DOHME CORP.

Showing 1 to 20 of 99 results